Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 61

1.

Primary adenoid cystic carcinoma of the trachea: clinical outcome of 38 patients after interdisciplinary treatment in a single institution.

Högerle BA, Lasitschka F, Muley T, Bougatf N, Herfarth K, Adeberg S, Eichhorn M, Debus J, Winter H, Rieken S, Uhl M.

Radiat Oncol. 2019 Jul 4;14(1):117. doi: 10.1186/s13014-019-1323-z.

2.

Definitive radiotherapy vs. postoperative radiotherapy for lower gingival carcinomas of the mandible : A single-center report about outcome and toxicity.

Lang K, Akbaba S, Held T, Kargus S, Horn D, Bougatf N, Bernhardt D, Freier K, Rieken S, Debus J, Adeberg S.

Strahlenther Onkol. 2019 Jul 2. doi: 10.1007/s00066-019-01484-z. [Epub ahead of print]

PMID:
31267170
3.

Management of Clinically Lymph Node-Positive Malignant Pleural Mesothelioma.

Verma V, Wegner RE, Adeberg S, Horne ZD, Grover S, Friedberg JS, Simone CB 2nd.

Semin Thorac Cardiovasc Surg. 2019 Jun 19. pii: S1043-0679(19)30177-7. doi: 10.1053/j.semtcvs.2019.06.004. [Epub ahead of print]

PMID:
31226401
4.

68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer.

Kratochwil C, Flechsig P, Lindner T, Abderrahim L, Altmann A, Mier W, Adeberg S, Rathke H, Röhrich M, Winter H, Plinkert PK, Marme F, Lang M, Kauczor HU, Jäger D, Debus J, Haberkorn U, Giesel FL.

J Nucl Med. 2019 Jun;60(6):801-805. doi: 10.2967/jnumed.119.227967. Epub 2019 Apr 6.

PMID:
30954939
5.

Re-irradiation in locally recurrent lung cancer patients.

Schlampp I, Rieber J, Adeberg S, Bozorgmehr F, Heußel CP, Steins M, Kappes J, Hoffmann H, Welzel T, Debus J, Rieken S.

Strahlenther Onkol. 2019 Apr 1. doi: 10.1007/s00066-019-01457-2. [Epub ahead of print]

PMID:
30937509
6.

Results of a combination treatment with intensity modulated radiotherapy and active raster-scanning carbon ion boost for adenoid cystic carcinoma of the minor salivary glands of the nasopharynx.

Akbaba S, Ahmed D, Lang K, Held T, Mattke M, Hoerner-Rieber J, Herfarth K, Rieken S, Plinkert P, Debus J, Adeberg S.

Oral Oncol. 2019 Apr;91:39-46. doi: 10.1016/j.oraloncology.2019.02.019. Epub 2019 Feb 27.

PMID:
30926061
7.

Clinical Management of Blood⁻Brain Barrier Disruptions after Active Raster-Scanned Carbon Ion Re-Radiotherapy in Patients with Recurrent Head-and-Neck Cancer.

Held T, Akbaba S, Lang K, Harrabi S, Bernhardt D, Freudlsperger C, Kargus S, Plinkert P, Rieken S, Herfarth K, Debus J, Adeberg S.

Cancers (Basel). 2019 Mar 19;11(3). pii: E383. doi: 10.3390/cancers11030383.

8.

Bimodal Radiotherapy with Active Raster-Scanning Carbon Ion Radiotherapy and Intensity-Modulated Radiotherapy in High-Risk Nasopharyngeal Carcinoma Results in Excellent Local Control.

Akbaba S, Held T, Lang K, Forster T, Federspil P, Herfarth K, Häfner M, Plinkert P, Rieken S, Debus J, Adeberg S.

Cancers (Basel). 2019 Mar 17;11(3). pii: E379. doi: 10.3390/cancers11030379.

9.

Early Response Assessment of Glioma Patients to Definitive Chemoradiotherapy Using Chemical Exchange Saturation Transfer Imaging at 7 T.

Meissner JE, Korzowski A, Regnery S, Goerke S, Breitling J, Floca RO, Debus J, Schlemmer HP, Ladd ME, Bachert P, Adeberg S, Paech D.

J Magn Reson Imaging. 2019 Mar 12. doi: 10.1002/jmri.26702. [Epub ahead of print]

PMID:
30864193
10.

Pre-Operative Versus Post-Operative Radiosurgery of Brain Metastases-Volumetric and Dosimetric Impact of Treatment Sequence and Margin Concept.

El Shafie RA, Tonndorf-Martini E, Schmitt D, Weber D, Celik A, Dresel T, Bernhardt D, Lang K, Hoegen P, Adeberg S, Paul A, Debus J, Rieken S.

Cancers (Basel). 2019 Mar 1;11(3). pii: E294. doi: 10.3390/cancers11030294.

11.

Salvage radiotherapy for recurrent hypopharyngeal and laryngeal squamous cell carcinoma (SCC) after first-line treatment with surgery alone: a 10-year single-centre experience.

Akbaba S, Held T, Lang K, Hoerner-Rieber J, Zaoui K, Forster T, Rieken S, Plinkert P, Debus J, Adeberg S.

Radiat Oncol. 2019 Feb 19;14(1):34. doi: 10.1186/s13014-019-1238-8.

12.

Carbon-ion radiotherapy in accelerated hypofractionated active raster-scanning technique for malignant lacrimal gland tumors: feasibility and safety.

Akbaba S, Lang K, Held T, Herfarth K, Rieber J, Plinkert P, Auffarth GU, Rieken S, Debus J, Adeberg S.

Cancer Manag Res. 2019 Feb 1;11:1155-1166. doi: 10.2147/CMAR.S190051. eCollection 2019.

13.

The role of organ- and function-preserving radiotherapy in the treatment of adenoid cystic carcinoma of the larynx.

Akbaba S, Lang K, Bulut OC, Held T, Rieken S, Plinkert P, Jensen A, Herfarth K, Debus J, Adeberg S.

Head Neck. 2019 Jul;41(7):2208-2214. doi: 10.1002/hed.25678. Epub 2019 Feb 5.

PMID:
30723979
14.

Outcome and prognostic factors following palliative craniospinal irradiation for leptomeningeal carcinomatosis.

El Shafie RA, Böhm K, Weber D, Lang K, Schlaich F, Adeberg S, Paul A, Haefner MF, Katayama S, Sterzing F, Hörner-Rieber J, Löw S, Herfarth K, Debus J, Rieken S, Bernhardt D.

Cancer Manag Res. 2019 Jan 17;11:789-801. doi: 10.2147/CMAR.S182154. eCollection 2019.

15.

Carbon irradiation overcomes glioma radioresistance by eradicating stem cells and forming an antiangiogenic and immunopermissive niche.

Chiblak S, Tang Z, Lemke D, Knoll M, Dokic I, Warta R, Moustafa M, Mier W, Brons S, Rapp C, Muschal S, Seidel P, Bendszus M, Adeberg S, Wiestler OD, Haberkorn U, Debus J, Herold-Mende C, Wick W, Abdollahi A.

JCI Insight. 2019 Jan 24;4(2). pii: 123837. doi: 10.1172/jci.insight.123837. [Epub ahead of print]

16.

Palliative Radiotherapy for Leptomeningeal Carcinomatosis-Analysis of Outcome, Prognostic Factors, and Symptom Response.

El Shafie RA, Böhm K, Weber D, Lang K, Schlaich F, Adeberg S, Paul A, Haefner MF, Katayama S, Hörner-Rieber J, Hoegen P, Löw S, Debus J, Rieken S, Bernhardt D.

Front Oncol. 2019 Jan 8;8:641. doi: 10.3389/fonc.2018.00641. eCollection 2018.

17.

Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy.

Bernhardt D, Aufderstrasse S, König L, Adeberg S, Bozorgmehr F, Christopoulos P, Shafie RAE, Hörner-Rieber J, Kappes J, Thomas M, Herth F, Steins M, Debus J, Rieken S.

Cancer Manag Res. 2018 Nov 30;10:6563-6569. doi: 10.2147/CMAR.S180990. eCollection 2018.

18.

Intensity Modulated Radiotherapy (IMRT) + Carbon Ion Boost for Adenoid Cystic Carcinoma of the Minor Salivary Glands in the Oral Cavity.

Lang K, Baur M, Akbaba S, Held T, Kargus S, Bougatf N, Bernhardt D, Freier K, Plinkert PK, Rieken S, Debus J, Adeberg S.

Cancers (Basel). 2018 Dec 4;10(12). pii: E488. doi: 10.3390/cancers10120488.

19.

Chemoradiation in female patients with anal cancer: Patient-reported outcome of acute and chronic side effects.

Koerber SA, Seither B, Slynko A, Haefner MF, Krug D, Liermann J, Adeberg S, Herfarth K, Debus J, Sterzing F.

Tumori. 2019 Apr;105(2):174-180. doi: 10.1177/0300891618811273. Epub 2018 Nov 28.

PMID:
30484384
20.

Advanced Radiation Techniques in the Treatment of Esthesioneuroblastoma: A 7-Year Single-Institution's Clinical Experience.

Liermann J, Syed M, Held T, Bernhardt D, Plinkert P, Jungk C, Unterberg A, Rieken S, Debus J, Herfarth K, Adeberg S.

Cancers (Basel). 2018 Nov 20;10(11). pii: E457. doi: 10.3390/cancers10110457.

Supplemental Content

Loading ...
Support Center